Literature DB >> 31172683

Patterns of health care use related to respiratory conditions in early life: A birth cohort study with linked administrative data.

Wenjia Chen1,2, Padmaja Subbarao3,4,5, Rachel E McGihon1, Laura Y Feldman1, Jingqin Zhu1,2, Wendy Lou6, Andrea S Gershon1,2,6,7, Kawsari Abdullah1, Theo J Moraes3,4, Aimée Dubeau3, Malcolm R Sears5, Diana L Lefebvre5, Stuart E Turvey8, Piush J Mandhane9, Meghan B Azad10, Teresa To1,2,6.   

Abstract

OBJECTIVES: To identify distinctive patterns of respiratory-related health services use (HSU) between birth and 3 years of age, and to examine associated symptom and risk profiles.
METHODS: This study included 729 mother and child pairs enrolled in the Toronto site of the Canadian Healthy Infant Longitudinal Development study in 2009-2012; they were linked to Ontario health administrative databases (2009-2016). A model-based cluster analysis was performed to identify distinct groups of children who followed a similar pattern of respiratory-related HSU between birth and 3 years of age, regarding hospitalization, emergency department (ED) and physician office visits for respiratory conditions and total health care costs (2016 Canadian dollars).
RESULTS: The majority (estimated cluster weight = 0.905) showed a pattern of low and stable respiratory care use (low HSU) while the remainder (weight = 0.095) showed a pattern of high use (high HSU). From 0 to 3 years of age, the low- and high-HSU groups differed in mean trajectories of total health care costs ($783 per 6 months decreased to $114, vs $1796 to $177, respectively). Compared to low-HSU, the high-HSU group was associated with a constant risk of hospitalizations, early high ED utilization and physician visits for respiratory problems. The two groups differed significantly in the timing of wheezing (late onset in low-HSU vs early in high-HSU) and future total costs (stable vs increased).
CONCLUSIONS: One in ten children had high respiratory care use in early life. Such information can help identify high-risk young children in a large population, monitor their long-term health, and inform resource allocation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  early life; health care use; medical costs; pattern; respiratory; young children

Mesh:

Year:  2019        PMID: 31172683     DOI: 10.1002/ppul.24381

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  4 in total

1.  Adenotonsillectomy, bronchoscopy and bronchoalveolar lavage in the management of preschool children with severe asthma: pilot study.

Authors:  Emma S Campisi; Myrtha E Reyna; May Brydges; Aimee Dubeau; Theo J Moraes; Paolo Campisi; Padmaja Subbarao
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-20       Impact factor: 2.503

2.  Risk of asthma in children diagnosed with bronchiolitis during infancy: protocol of a longitudinal cohort study linking emergency department-based clinical data to provincial health administrative databases.

Authors:  Kawsari Abdullah; Deshayne B Fell; Dhenuka Radhakrishnan; Steven Hawken; David W Johnson; Piush Mandhane; Teresa To; Gary Joubert; Amy C Plint
Journal:  BMJ Open       Date:  2021-05-03       Impact factor: 2.692

3.  Aberrant newborn T cell and microbiota developmental trajectories predict respiratory compromise during infancy.

Authors:  Andrew McDavid; Nathan Laniewski; Alex Grier; Ann L Gill; Haeja A Kessler; Heidie Huyck; Elizabeth Carbonell; Jeanne Holden-Wiltse; Sanjukta Bandyopadhyay; Jennifer Carnahan; Andrew M Dylag; David J Topham; Ann R Falsey; Mary T Caserta; Gloria S Pryhuber; Steven R Gill; Kristin M Scheible
Journal:  iScience       Date:  2022-03-01

4.  Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's disease.

Authors:  Konstantinos Poulakis; Joana B Pereira; J-Sebastian Muehlboeck; Lars-Olof Wahlund; Örjan Smedby; Giovanni Volpe; Colin L Masters; David Ames; Yoshiki Niimi; Takeshi Iwatsubo; Daniel Ferreira; Eric Westman
Journal:  Nat Commun       Date:  2022-08-05       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.